If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenus Regulatory News (GNS)

Share Price Information for Genus (GNS)

Share Price is delayed by 15 minutes
Get Live Data
2,290.00    -22.00 (-0.95%)
Bid:
2,288.00
Ask:
2,292.00
Spread: 4.00 (0.175%)
Market Cap: £1.52b
GNS Live PriceLast checked at - London Stock Exchange

Intraday Genus Share Chart

Director/PDMR Shareholding

14 Sep 2017 17:30

RNS Number : 8203Q
Genus PLC
14 September 2017
 

14 September 2017

 

Genus plc

 

Director/PDMR Shareholding

 

Genus plc (LSE: GNS) announces that yesterday conditional nil-cost share options were granted under the Genus 2014 Performance Share Plan over ordinary shares in Genus to the Executive Directors and members of the Genus Executive Leadership Team ('GELT') as listed in table A below. In addition, following Genus's compulsory deferral requirements relating to the annual bonus earned by Executive Directors and GELT for the financial year ending 30 June 2017, nil-cost share options were granted over ordinary shares under Genus's Deferred Share Bonus Plan as listed in table B below.

Details of the performance conditions that apply to the nil-cost share options can be found in the Directors' Remuneration Report of the Genus 2017 Annual Report.

The below notifications, made in accordance with the requirements of the EU Market Abuse Regulation, give further detail of the nil-cost share option awards made on 13 September 2017.

 

For further information please contact:

 

Genus:

Cara Crichton, Deputy Company Secretary Tel: +44 (0)1256 347100

 

Table A - GELT 2014 Performance Share Plan Options

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

1. Karim Bitar

2. Stephen Wilson

3. Bill Christianson

4. Nate Zwald

5. Jerry Thompson

6. Jonathan Lightner

7. Angelle Rosata

8. Dan Hartley

2.

Reason for the notification

a.

Position/status

1. Chief Executive

2. Group Finance Director

3. Chief Operating Officer Genus PIC

4. Chief Operating Officer Genus ABS Dairy

5. Chief Operating Officer Genus ABS Beef

6. Chief Scientific Officer & Head of Genus R&D

7. Group Human Resources Director

8. Group General Counsel & Company Secretary

b.

Initial notification

/Amendment

 

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Genus plc

b.

LEI

54930022EOITNKSIGH56

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each.

 

 

GB0002074580

b.

Nature of the transaction

Award of nil-cost share options granted under the Genus plc 2014 Performance Share plan over ordinary shares in Genus.

 

c.

Price(s) and volume(s)

Numbers 1 to 8 in the left hand column correspond to the relevant PDMR as detailed in boxes 1a and 2a above.

 

Price(s)

 

Volume(s)

1. 1,972.67p

56,404

2. 1,972.67p

38,221

3. 1,972.67p

22,278

4. 1,972.67p

18,661

5. 1,972.67p

18,661

6. 1,972.67p

22,278

7. 1,972.67p

17,800

8. 1,972.67p

19,009

d.

Aggregated information

· Aggregated volume

· Price

 

 

 

n/a

 

e.

Date of the transaction

2017-09-13

f.

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

 

Table B - GELT Deferred Share Bonus Plan Options

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

1. Karim Bitar

2. Stephen Wilson

3. Bill Christianson

4. Nate Zwald

5. Jerry Thompson

6. Jonathan Lightner

7. Dan Hartley

 

2.

Reason for the notification

a.

Position/status

1. Chief Executive

2. Group Finance Director

3. Chief Operating Officer Genus PIC

4. Chief Operating Officer Genus ABS Dairy

5. Chief Operating Officer Genus ABS Beef

6. Chief Scientific Officer & Head of Genus R&D

7. Group General Counsel & Company Secretary

b.

Initial notification

/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Genus plc

b.

LEI

54930022EOITNKSIGH56

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each.

 

 

GB0002074580

b.

Nature of the transaction

Award of nil-cost share options granted under Genus's Deferred Share Bonus Plan following the compulsory deferral of 25% of annual bonus in respect of bonuses earned in the financial year ending 30 June 2017.

 

c.

Price(s) and volume(s)

Numbers 1 to 7 in the left hand column correspond to the relevant PDMR as detailed in boxes 1a and 2a above.

 

Price(s)

 

Volume(s)

1. 1,972.67p

20,629

2. 1,972.67p

10,213

3. 1,972.67p

2,017

4. 1,972.67p

557

5. 1,972.67p

615

6. 1,972.67p

7,463

7. 1,972.67p

6,395

d.

Aggregated information

· Aggregated volume

· Price

 

 

 

n/a

e.

Date of the transaction

2017-09-13

f.

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHUSUNRBKAKAAR
Date   Source Headline
2nd Apr 200812:00 pmRNSMerger Update
1st Apr 20085:33 pmRNSDirector/PDMR Shareholding
31st Mar 20084:00 pmRNSTotal Voting Rights
31st Mar 20084:00 pmRNSBlocklisting Interim Review
20th Mar 20082:08 pmRNSHolding(s) in Company
17th Mar 20083:21 pmRNSHolding(s) in Company
13th Mar 20082:00 pmRNSHolding(s) in Company
29th Feb 20082:00 pmRNSTotal Voting Rights
27th Feb 20085:02 pmRNSDirector/PDMR Shareholding
26th Feb 20084:54 pmRNSDirector/PDMR Shareholding
26th Feb 20087:00 amRNSInterim Results
22nd Feb 200811:56 amRNSHolding(s) in Company
31st Jan 20082:00 pmRNSBlocklisting Interim Review
17th Jan 20087:00 amRNSBoard Changes
15th Jan 20088:00 amRNS1st dealings on AIM
15th Jan 20088:00 amRNSDisposal
14th Jan 20085:40 pmRNSHolding(s) in Company
9th Jan 200811:00 amRNSAppointment of New Adviser
2nd Jan 20083:15 pmRNSTotal Voting Rights
30th Nov 20078:00 amRNSTotal Voting Rights
27th Nov 20077:01 amRNSDisposal
15th Nov 20073:39 pmRNSResult of AGM
15th Nov 20077:01 amRNSAGM Statement
12th Nov 20078:24 amRNSAdmission to Official List
12th Nov 20078:00 amRNSCancellation - 12/11/2007
7th Nov 20077:57 amRNSPublication of Prospectus
6th Nov 200712:51 pmRNSHolding(s) in Company
6th Nov 20077:00 amRNSDisposal
1st Nov 20075:53 pmRNSDirector/PDMR Shareholding
1st Nov 20077:02 amRNSPlacing
31st Oct 20079:20 amRNSTotal Voting Rights
18th Oct 20072:30 pmRNSDirector/PDMR Shareholding
12th Oct 20077:01 amRNSMove to the Official List
4th Oct 20077:01 amRNSDisposal of SyAqua Mexico
28th Sep 20077:01 amRNSTotal Voting Rights
24th Sep 20072:11 pmRNSDirector/PDMR Shareholding
18th Sep 20077:02 amRNSPreliminary Results
12th Sep 20072:55 pmRNSStatement re: Foot & Mouth
5th Sep 20075:16 pmRNSBlocklisting Interim Review
17th Aug 20072:55 pmRNSChange of Adviser
10th Aug 20074:28 pmRNSAIM Rule 26
6th Aug 20077:01 amRNSStatement Re: Foot & Mouth
25th Jul 20072:00 pmRNSBlocklisting Interim Review
18th Jul 20077:01 amRNSPre-Close Trading Update
7th Jun 20076:35 pmRNSHolding(s) in Company
7th Jun 20076:33 pmRNSHolding(s) in Company
19th Apr 20075:13 pmRNSDirector/PDMR Shareholding
12th Apr 200710:58 amRNSHolding(s) in Company
29th Mar 20077:00 amRNSHolding(s) in Company
13th Mar 20077:02 amRNSBoard Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.